The challenges that now remain include elucidating the precise site of action and mechanism of Adcy3 that make it an important contributor to obesity or resistance to obesity, identifying the exact genetic variation in human populations that contributes to or protects from obesity, and designing pharmacological interventions based on Adcy3 that promote fitness. Here, ADCY3 is linked to obesity disorder.